TMCI
Treace Medical Concepts Inc (TMCI)
Healthcare • NASDAQ • $2.01+4.69%
- Symbol
- TMCI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $2.01
- Daily Change
- +4.69%
- Market Cap
- $130.22M
- Trailing P/E
- N/A
- Forward P/E
- -2.23
- 52W High
- $7.78
- 52W Low
- $1.17
- Analyst Target
- $4.25
- Dividend Yield
- N/A
- Beta
- 1.11
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoa…
Company websiteResearch TMCI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.